Back to results
CompletedPhase 3

PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection

NCT03079011

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centre Hospitalier Universitaire

Amiens, France

+81 additional locations

View on ClinicalTrials.gov